McKesson

McKesson, Cardinal Health and AmerisourceBergen (now Cencora) agreed to pay up to $21 billion over 18 years to resolve opioid claims brought by states and local governments - effective April 2, 2022 (per McKesson's FY2022 Form 10-K), with payments now under way according to the national settlement administrator, and none of the companies admitting wrongdoing. The allegation was not that they made the drugs but that they failed to monitor and report suspicious orders, allowing diversion into illegal channels. The injunctive term is the one worth noting: the settlement required the three distributors to build and maintain an independent centralised clearinghouse giving regulators aggregated distribution data through roughly 2032 - a data-sharing obligation imposed as a remedy, which is the inverse of every other finding in this tracker.

• Severity
• Evidence tierUnassigned
• Claims confirmed
• Last verified2026-08-04

Case status. Private litigation; the legal tier of its sources has not been assigned yet.

Primary source. nationalopioidsettlement.com/executive-summary/ — Verified - primary source confirmed.

Arbitration

Not independently confirmed this pass — standard binding arbitration + class action waiver expected.

Contacts

Privacy contact. Not recorded.

Legal notice. Not verified this pass. If publicly traded: SEC Form 10-K cover page gives the official corporate address; the Secretary of State business-entity search in the state of incorporation gives the registered agent, which must accept service. If private: the state registered agent is usually the only reliable route.

Mailing address. Not recorded.